On 2025-05-14, Telomir Pharmaceuticals, Inc. (TELO) announced earnings per share of $-0.07 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.10.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.08 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.10 | $-0.07 |
| 2025-02-04 | 2024-12-31 | $-0.05 | $-0.10 |
| 2024-11-12 | 2024-09-30 | -- | $-0.20 |
| 2024-08-13 | 2024-06-30 | -- | $-0.05 |
| 2024-05-13 | 2024-03-31 | -- | $-0.23 |